CIK 0001723128 · Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- Phone
- (908) 947-3120
- Former names
- Atlas Holdings, Inc.
- SC 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Executive Vice President sold 62,711 shares at an average $7.84 ($491,382)
- 4 Open-market sale Executive Vice President sold 100,000 shares at $7.75 ($775,000)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market sale Director sold 38,000 shares at an average $6.74 ($256,106)
- 144 Insider Sale of Securities
- 4 Option exercise Director acquired 76,453 shares (option exercise)
- 4 Option exercise Director acquired 76,453 shares (option exercise)
- 4 Option exercise Director acquired 107,034 shares (option exercise)
- 4 Option exercise Director acquired 76,453 shares (option exercise)
- 4 Option exercise Director acquired 76,453 shares (option exercise)
- 4 Option exercise Director acquired 76,453 shares (option exercise)
- 4 Option exercise Director acquired 76,453 shares (option exercise)
- 4 Option exercise Director acquired 76,453 shares (option exercise)
Page 10 of 35 · 695 filings